How to Commercialise Your PhD in Life Sciences - Health Talks
Welcome to the next event from the Health Talks series - health, life sciences and entrepreneurship talks organised by Aalto University, Centria Health Hub, Health Design, Health Hub Tampere, HealthHub Finland EDIH, Healthtech Finland, Health Turku, HiLIFE (University of Helsinki), Kuopio Health, OuluHealth and Terkko Health Hub.
In this Health Talks, we will look at the paths that PhD researchers can undertake to commercialise their idea.
Doing a PhD often feels like a natural step of a prospecting academic career, which usually leads to a postdoc or a researcher positions and occasionally down the line to a professorship. However, it doesn't need to be so, and there are many ways how a PhD and the concepts one works on during the programme can benefit the world already now. In this event, we will hear inspiring stories of doctoral researchers who decided to follow an unconventional path and take steps in commercialising their promising results.
- 28.09, 09:30 - 11:00
- Online in Zoom
09:30 – Welcome to today’s Health Talks by Terkko, Aalto and HiLIFE
09:45 – Anna Ptukha, University of Helsinki
10:15 – Yohann Le Bourlout, Aalto University
10:45 – Closing words
Anna Ptukha is a PhD researcher at the Doctoral Programme Brain and Mind, and a master's student in Translation Medicine, University of Helsinki. She is the co-founder of MIND'S EYE – a startup developing timely diagnostics of developmental conditions with eye tracking. She is also creating a low-cost, rapid and accessible ADHD diagnostic tool for middle school children in a commercialization project at the University of Helsinki.
Yohann Le Bourlout is a PhD researcher at the Department of Neuroscience and Biomedical Engineering, Aalto University. Together with his supervisor Heikki Nieminen, he is developing an ultrasonically actuated medical needle that can improve treatment and reduce discomfort of such interventions as biopsy. The commercialization steps of the device are just about to start, and it was recently tested in practice.
Thermo Fisher and UPM seminar
Special Seminar by Melissa Little
Professor Melissa Little, AC, BSc (Hons I), PhD, GAICD, FAAHMS, FAAS, is CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Executive Director of reNEW Copenhagen, Chief Scientist at the Murdoch Children’s Research Institute, and leader of the Kidney Regeneration Laboratory, Melbourne, Australia where she holds an NHMRC Senior Principal Research Fellow. Melissa is the Immediate Past President of the International Society for Stem Cell Research and holds an honorary position as Professor in the Department of Pediatrics, University of Melbourne.
Dissertation: Johanna Joensuu
Opponent: professor Kaarin Mäkikallio, University of Turku
Dissertation: Martta Jokinen
Opponent: professori Timo Hautala, University of Oulu